179 related articles for article (PubMed ID: 17297551)
1. In vivo bioluminescence tumor imaging of RGD peptide-modified adenoviral vector encoding firefly luciferase reporter gene.
Niu G; Xiong Z; Cheng Z; Cai W; Gambhir SS; Xing L; Chen X
Mol Imaging Biol; 2007; 9(3):126-34. PubMed ID: 17297551
[TBL] [Abstract][Full Text] [Related]
2. Imaging chemically modified adenovirus for targeting tumors expressing integrin alphavbeta3 in living mice with mutant herpes simplex virus type 1 thymidine kinase PET reporter gene.
Xiong Z; Cheng Z; Zhang X; Patel M; Wu JC; Gambhir SS; Chen X
J Nucl Med; 2006 Jan; 47(1):130-9. PubMed ID: 16391197
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
[TBL] [Abstract][Full Text] [Related]
4. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
[TBL] [Abstract][Full Text] [Related]
5. Genetically modified adenovirus vector containing an RGD peptide in the HI loop of the fiber knob improves gene transfer to nonhuman primate isolated pancreatic islets.
Bilbao G; Contreras JL; Dmitriev I; Smyth CA; Jenkins S; Eckhoff D; Thomas F; Thomas J; Curiel DT
Am J Transplant; 2002 Mar; 2(3):237-43. PubMed ID: 12096786
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
7. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
8. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
[TBL] [Abstract][Full Text] [Related]
9. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
[TBL] [Abstract][Full Text] [Related]
10. Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus.
Granio O; Porcherot M; Corjon S; Kitidee K; Henning P; Eljaafari A; Cimarelli A; Lindholm L; Miossec P; Boulanger P; Hong SS
J Virol; 2009 Jun; 83(12):6048-66. PubMed ID: 19357170
[TBL] [Abstract][Full Text] [Related]
11. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
12. Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation.
Koizumi N; Mizuguchi H; Sakurai F; Yamaguchi T; Watanabe Y; Hayakawa T
J Virol; 2003 Dec; 77(24):13062-72. PubMed ID: 14645563
[TBL] [Abstract][Full Text] [Related]
13. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
[TBL] [Abstract][Full Text] [Related]
14. Targeting of high-capacity adenoviral vectors.
Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive imaging of transcriptionally restricted transgene expression following intratumoral injection of an adenovirus in which the COX-2 promoter drives a reporter gene.
Liang Q; Yamamoto M; Curiel DT; Herschman HR
Mol Imaging Biol; 2004; 6(6):395-404. PubMed ID: 15564150
[TBL] [Abstract][Full Text] [Related]
16. Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma.
Kawashima H; Ogose A; Yoshizawa T; Kuwano R; Hotta Y; Hotta T; Hatano H; Kawashima H; Endo N
Cancer Sci; 2003 Jan; 94(1):70-5. PubMed ID: 12708477
[TBL] [Abstract][Full Text] [Related]
17. Engineering conditionally replication-competent adenoviral vectors carrying the cytosine deaminase gene increases the infectivity and therapeutic effect for breast cancer gene therapy.
Liu Y; Ye T; Maynard J; Akbulut H; Deisseroth A
Cancer Gene Ther; 2006 Apr; 13(4):346-56. PubMed ID: 16179927
[TBL] [Abstract][Full Text] [Related]
18. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability.
Eto Y; Gao JQ; Sekiguchi F; Kurachi S; Katayama K; Maeda M; Kawasaki K; Mizuguchi H; Hayakawa T; Tsutsumi Y; Mayumi T; Nakagawa S
J Gene Med; 2005 May; 7(5):604-12. PubMed ID: 15543536
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral versus intravenous gene therapy using a transcriptionally targeted viral vector in an orthotopic hepatocellular carcinoma rat model.
Kim YI; Ahn BC; Ronald JA; Katzenberg R; Singh A; Paulmurugan R; Ray S; Gambhir SS; Hofmann LV
J Vasc Interv Radiol; 2012 May; 23(5):704-11. PubMed ID: 22387029
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive of adenovirus tumor retargeting in living subjects by a soluble adenovirus receptor-epidermal growth factor (sCAR-EGF) fusion protein.
Liang Q; Dmitriev I; Kashentseva E; Curiel DT; Herschman HR
Mol Imaging Biol; 2004; 6(6):385-94. PubMed ID: 15564149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
